Please provide your email address to receive an email when new articles are posted on . The FDA recently approved Adzenys XR-ODT for the treatment of attention ...

The US Food and Drug Administration (FDA) has approved an amphetamine extended-release orally disintegrating tablet (Adzenys XR-ODT) for the treatment of attention ...

Neos Therapeutics Inc. recently announced the FDA approved Cotempla XR-ODT, an extended-release orally disintegrating tablet, for the treatment of ADHD in children aged 6 to 17 years. “Cotempla XR-ODT ...

Objective: To compare the flavour and taste preferences of two acid-inhibitory therapies in children. Subjects and Setting: 104 (52 male and 52 female) healthy children aged 6-11 years participated in ...

Rizatriptan (as benzoate) 10mg; orally-disintegrating tabs; peppermint flavor; contains phenylalanine. Maxalt-MLT Orally Disintegrating Tablets, 10 mg, are white to off-white, round lyophilized orally ...

Omeprazole ODT utilizes MelTech technology that allows the tablet to dissolve in the mouth without water. Perrigo announced the launch of store brand Omeprazole Delayed Release Orally Disintegrating ...

MNMD is developing its lead pipeline candidate MM120, an orally disintegrating tablet (ODT) and a pharmaceutically optimized ...

(RTTNews) - Viatris (VTRS) announced the launch in Canada of Gen-Clozapine orally disintegrating tablets, providing a new treatment option for treatment-resistant schizophrenia patients. This marks ...

(RTTNews) - Endo USA, Inc., affiliated to generics and specialty branded pharmaceutical company Endo, Inc., is recalling one lot of Par Pharmaceutical, Inc.'s Clonazepam Orally Disintegrating Tablets, ...

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and ...

Dublin, Oct. 09, 2025 (GLOBE NEWSWIRE) -- The "Orally Disintegrating Tablet Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By ...

Neos Therapeutics hopes novel drug delivery will help newly approved Adzenys XR-ODT outcompete generic rivals in the ADHD drug market. The tablet disintegrates in the mouth and does not need to be ...